Hepatocellular Cancer Completed Phase 2 Trials for Carotuximab (DB06322)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01375569TRC105 for Liver Cancer That Has Not Responded to SorafenibTreatment